Suppression of acute morphine withdrawal syndrome by adenovirus-mediated β-endorphin in rats

Brain Research

Volumn 1422, Issue , 2011, Pages 13-19

  He, Yan ^a,b   Wu, Fei Xiang ^a   Miao, Xue Rong ^a   Xu, Xue Wu ^a   Sun, Yu Ming ^a   Chen, Cai Yang ^a   Yu, Wei Feng ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b Department of Anesthesiology   (China)

Author keywords

Adenovirus; Endorphin; Gene therapy; Morphine dependent; Withdrawal syndrome

Indexed keywords

ADENOVIRUS VECTOR; BETA ENDORPHIN; MORPHINE; NALOXONE; OPIATE;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID LEVEL; CONTROLLED STUDY; DRUG DOSE ESCALATION; ILEUM; IMMUNOHISTOCHEMISTRY; INTESTINE CONTRACTION; MALE; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; SCORING SYSTEM; WITHDRAWAL SYNDROME;

ACUTE DISEASE; ADENOVIRIDAE; ANIMALS; BETA-ENDORPHIN; DISEASE MODELS, ANIMAL; GENE THERAPY; GENETIC VECTORS; HEK293 CELLS; HUMANS; MALE; MORPHINE; MORPHINE DEPENDENCE; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANCE WITHDRAWAL SYNDROME;

ADENOVIRIDAE; RATTUS;

EID: 80054858040     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2011.07.063     Document Type: Article

References (39)

1. M. Barrios, and J.M. Baeyens Differential effects of calcium channel blockers and stimulants on morphine withdrawal in vitro Eur. J. Pharmacol. 152 1988 175 178
2. A. Bisaga, and P. Popik In search of a new pharmacological treatment for drug and alcohol addiction: N-methyl-d-aspartate (NMDA) antagonists Drug Alcohol Depend. 59 2000 1 15 (Pubitemid 30116834)
3. C. Bond, K.S. LaForge, M. Tian, D. Melia, S. Zhang, and L. Borg Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction Proc. Natl. Acad. Sci. 95 1998 9608 9613 (Pubitemid 28506279)
4. H. Cao, D.R. Koehler, and J. Hu Adenoviral vectors for gene replacement therapy Viral Immunol. 17 2004 327 333 (Pubitemid 39244755)
5. A. Capasso, and A. Loizzo Beta-endorphin fragments (DT gamma E and DE gamma E) reduce opiate withdrawal in guinea pig ileum Prog. Neuropsychopharmacol. Biol. Psychiatry. 26 2002 313 319 (Pubitemid 34038060)
6. S. Cavun, G. Göktalay, and W.R. Millington Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal J. Pharmacol. Exp. Ther. 315 2005 949 958 (Pubitemid 41500762)
7. J.A. Culpepper-Morgan, and M.J. Kreek Hypothalamic-pituitary-adrenal axis hypersensitivity to naloxone in opioid dependence: a case of naloxone induced withdrawal Metabolism 46 1997 130 134 (Pubitemid 27078754)
8. Y. Dai, E.M. Schwarz, D. Gu, W.W. Zhang, N. Sarvetnick, and I.M. Verma Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression Proc. Natl. Acad. Sci. 92 1995 1401 1405
9. A.A. Finegold, A.J. Mannes, and M.J. Iadarola A paracrine paradigm for in vivo gene therapy in the central nervous system: treatment of chronic pain Hum. Gene Ther. 10 1999 1251 1257 (Pubitemid 29231867)
10. B.H. Gabra, E.A. Afify, T.T. Daabees, and M.S. Abou Zeit-Har The role of the NO/NMDA pathways in the development of morphine withdrawal induced by naloxone in vitro Pharmacol. Res. 51 2005 319 327 (Pubitemid 40430805)
11. C.C. Gartry, E. Oviedo-Joekes, N. Laliberté, and M.T. Schechter NAOMI: the trials and tribulations of implementing a heroin assisted treatment study in North America Harm. Reduct. J. 6 2009 2
12. K.P. Gudehithlu, G.A. Tejwani, and H.N. Bhargava Beta-endorphin and methionine-enkephalin levels in discrete brain regions, spinal cord, pituitary gland and plasma of morphine tolerant-dependent and abstinent rats Brain Res. 553 1991 284 290
13. K. Ishii, M. Isono, R. Inoue, and S. Hori Attempted gene therapy for intractable pain: dexamethasone-mediated exogenous control of beta-endorphin secretion in genetically modified cells and intrathecal transplantation Exp. Neurol. 166 2000 90 98
14. R.R. Ji, K. Befort, G.J. Brenner, and C.J. Woolf ERK MAP kinase activation in superficial spinal cord neurons induces prodynorphin and NK-1 up-regulation and contributes to persistent inflammatory pain hypersensitivity J. Neurosci. 22 2002 478 485 (Pubitemid 34049086)
15. R.E. Johnson, M.A. Chutuape, E.C. Strain, S.L. Walsh, M.L. Stitzer, and G.E. Bigelow A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence N. Engl. J. Med. 343 2000 1290 1297
16. J.A. Kennedy, N. Hartman, R. Sbriglio, E. Khuri, and M.J. Kreek Metyrapone-induced withdrawal symptoms Br. J. Addict. 85 1990 1133 1140 (Pubitemid 20292812)
17. T.R. Kosten, M.J. Kreek, J. Ragunath, and H.D. Kleber A preliminary study of beta endorphin during chronic naltrexone maintenance treatment in ex-opiate addicts Life Sci. 39 1986 55 59 (Pubitemid 16090938)
18. M.B. Leal, K. Michelin, D.O. Souza, and E. Elisabetsky Ibogaine attenuation of morphine withdrawal in mice: role of glutamate N-methyl-d-aspartate receptors Prog. Neuropsychopharmacol. Biol. Psychiatry. 27 2003 781 785 (Pubitemid 36969805)
19. S. Liu, W. Zhou, H. Liu, G. Yang, and W. Zhao Electroacupuncture attenuates morphine withdrawal signs and c-Fos expression in the central nucleus of the amygdala in freely moving rats Brain Res. 1044 2005 155 163 (Pubitemid 40693448)
20. W. Liu, W. Feng, F. Wang, W. Li, B. Zhou, C. Gao, Y. Li, Y. Kong, M. Ma, and S. Fu Adenovirus-mediated ICOSIg gene transfer alleviates cardiac remodeling in experimental autoimmune myocarditis Immunol. Cell Biol. 86 2008 659 665
21. J.N. Lozier, G. Csako, T.H. Mondoro, D.M. Krizek, M.E. Metzger, and R. Costello Toxicity of a first-generation adenoviral vector in rhesus macaques Hum. Gene Ther. 13 2002 113 124 (Pubitemid 34075175)
22. R. Maldonado, S. Negus, and G.F. Koob Precipitation of morphine withdrawal syndrome in rats by administration of mu-, delta- and kappa-selective opioid antagonists Neuropharmacology 31 1992 1231 1241 (Pubitemid 23002106)
23. P. Manzoni, S. Brochu, B. Fischer, and R. Rehm Determinants of property crime among illicit opiate users outside of treatment across Canada Deviant Behav. 27 2006 351 376 (Pubitemid 44011816)
24. J.C. March, E. Oviedo-Joekes, and M. Romero Drugs and social exclusion in ten European cities Eur. Addict. Res. 12 2006 33 41 (Pubitemid 41797962)
25. M. Mata, J.C. Glorioso, and D.J. Fink Gene therapy: novel treatments for polyneuropathy and chronic pain Curr. Neurol. Neurosci. Rep. 4 2004 1 2 (Pubitemid 38899045)
26. P. Mayer, and V. Höllt Pharmacogenetics of opioid receptors and addiction Pharmacogenet Genomics 16 2006 1 7 (Pubitemid 41803871)
27. C.L. Miller, T. Kerr, J.C. Frankish, P.M. Spittal, K. Li, M.T. Schechter, and E. Wood Binge drug use independently predicts HIV seroconversion among injection drug users: implications for public health strategies Subst. Use Misuse. 41 2006 199 210 (Pubitemid 43068283)
28. K. Niikura, M. Narita, D. Okutsu, Y. Tsurukawa, K. Nanjo, and K. Kurahashi Implication of endogenous beta-endorphin in the inhibition of the morphine-induced rewarding effect by the direct activation of spinal protein kinase C in mice Neurosci. Lett. 433 2008 54 58
29. R. Nirogi, V. Kandikere, K. Mudigonda, G. Bhyrapuneni, N. Muddana, and R. Saralaya A simple and rapid method to collect the cerebrospinal fluid of rats and its application for the assessment of drug penetration into the central nervous system J. Neurosci. Methods 178 2009 116 119
30. E. Oviedo-Joekes, S. Brissette, D.C. Marsh, P. Lauzon, D. Guh, and A. Anis Diacetylmorphine versus methadone for the treatment of opioid addiction N. Engl. J. Med. 361 2009 777 786
31. S.E. Raper, M. Yudkoff, N. Chirmule, G.P. Gao, F. Nunes, and Z.J. Haskal A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency Hum. Gene Ther. 13 2002 163 175 (Pubitemid 34075180)
32. J.M. Van Reem Endorphines and addiction Eur. Neuropsychopharmacol. 15 2005 S97 S98
33. I. Roth-Deri, T. Green-Sadan, and G. Yadid Beta-endorphin and drug-induced reward and reinforcement Prog. Neurobiol. 86 2008 1 21
34. T. Seki, H. Matsubayashi, T. Amano, K. Kitada, T. Serikawa, and M. Sasa Adenoviral gene transfer of aspartoacylase ameliorates tonic convulsions of spontaneously epileptic rats Neurochem. Int. 45 2004 171 178 (Pubitemid 38479576)
35. J.M. Van Ree, R.J. Niesink, L. Van Wolfswinkel, N.F. Ramsey, M.M. Kornet, and W.R. Van Furth Endogenous opioids and reward Eur. J. Pharmacol. 405 2000 89 101
36. E. Wood, K. Li, A. Palepu, D.C. Marsh, M.T. Schechter, R.S. Hogg, J.S. Montaner, and T. Kerr Sociodemographic disparities in access to addiction treatment among a cohort of Vancouver injection drug users Subst. Use Misuse 40 2005 1153 1167 (Pubitemid 41077345)
37. H. Xiao, D.X. Zhai, B.B. Yan, J.H. Wang, W.S. Xu, and G.Y. Wang A role for the parafascicular thalamic nucleus in the development of morphine dependence and withdrawal Brain Res. 1271 2009 74 82
38. X.W. Xu, S.J. Pei, X.R. Miao, and W.F. Yu Human signal peptide had advantage over mouse in secretory expression Histochem. Cell Biol. 132 2009 239 246
39. Y. Zhang, N. Chirmule, G.P. Gao, R. Qian, M. Croyle, and B. Joshi Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages Mol. Ther. 3 2001 697 707 (Pubitemid 32509867)